Newbridge Financial Services Group, Inc. Novavax Inc Transaction History

Newbridge Financial Services Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$5.76 - $12.48 $576 - $1,248	-100 Reduced 94.34%	6 $0
Q4 2022 Jan 17, 2023	SELL	$8.86 - $25.04 $3,659 - $10,341	-413 Reduced 79.58%	106 $0
Q1 2022 Apr 26, 2022	SELL	$69.73 - $142.9 $6,973 - $14,290	-100 Reduced 16.16%	519 $38,000
Q4 2021 Jan 19, 2022	BUY	$134.56 - $217.97 $82,485 - $133,615	613 Added 10216.67%	619 $89,000
Q1 2021 Sep 07, 2021	BUY	$112.98 - $319.93 $677 - $1,919	6 New	6 $1,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.